Jewish General Hospital

TAD

NCT04671511

Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer (TADEN)

Status:

Recruiting

26459-200.png

Phase

Line of Therapy.png

Neoajduvant

Line of Therapy

Disease Stage.png

Early Cancer

Disease Stage

Target.png

Biomarker(s)

Investigational

Product

n/a

Sentinel node biopsy and clipping and removing node

Treatment Arms

o Targeted Axillary Dissection